Troikaa Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 68.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 62.55 Cr
as on 24-10-2024
- Company Age 30 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1,077.62 Cr
as on 24-10-2024
- Satisfied Charges ₹ 110.67 Cr
as on 24-10-2024
- Revenue 6.27%
(FY 2023)
- Profit -126.64%
(FY 2023)
- Ebitda -52.13%
(FY 2023)
- Net Worth -2.17%
(FY 2023)
- Total Assets 15.32%
(FY 2023)
About Troikaa Pharmaceuticals
The Corporate was formerly known as Troikaa Exports Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 68.00 Cr and a paid-up capital of Rs 62.55 Cr.
The company currently has active open charges totaling ₹1,077.62 Cr. The company has closed loans amounting to ₹110.67 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Troikaa Pharmaceuticals Limited India are Umang Desai as COMPANY SECRETARY and Jagrut Desai as Cfo. Ketan Patel, Milan Patel, Sushma Patel, and Six other members serve as directors at the Company.
- CIN/LLPIN
U24100GJ1994PLC022162
- Company No.
022162
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
31 May 1994
- Date of AGM
01 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Troikaa Pharmaceuticals Limited offer?
Troikaa Pharmaceuticals Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Anesthetic, Pharmaceutical Medicine, Pharmaceutical Syrup, Dry Syrups, Generic Pharmaceuticals, Skin Care Cosmetics, Skin Gel, Anti Infective Agent, Antiprotozoal Drug.
Who are the key members and board of directors at Troikaa Pharmaceuticals?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Milan Patel  | Managing Director | 31-May-1994 | Current |
| Ketan Patel | Managing Director | 31-May-1994 | Current |
| Umang Desai | Company Secretary | 16-Jan-2021 | Current |
| Jagrut Desai | CFO | 14-Mar-2022 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subir Das | Director | 03-Feb-2020 | Current |
| Asheel Patel | Whole-Time Director | 01-Apr-2021 | Current |
Sushma Patel  | Whole-Time Director | 02-May-2016 | Current |
| Binita Patel | Whole-Time Director | 02-May-2016 | Current |
| Achyutkumar Patel | Whole-Time Director | 24-Oct-2015 | Current |
| Prakash Shah | Director | 08-Aug-2023 | Current |
Financial Performance and Corporate Structure Insights of Troikaa Pharmaceuticals.
Troikaa Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.27% increase. The company also saw a substantial fall in profitability, with a 126.64% decrease in profit. The company's net worth dipped by a decrease of 2.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Troikaa Pharmaceuticals?
In 2023, Troikaa Pharmaceuticals had a promoter holding of 97.59% and a public holding of 2.41%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Oct 2024 | ₹1.62 M | Open |
Others Creation Date: 27 Sep 2024 | ₹60.00 Cr | Open |
Hdfc Bank Limited Creation Date: 06 Jul 2024 | ₹3.27 M | Open |
How Many Employees Work at Troikaa Pharmaceuticals?
Troikaa Pharmaceuticals has a workforce of 3289 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Troikaa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Troikaa Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
